Key result
A novel microarray-based individual platelet adhesion assay successfully quantified the effects of antiplatelet therapies, correlating well with standard flow cytometry and aggregometry techniques.
Why the study?
Does the Individual Platelet Adhesion Assay accurately measure platelet function and the effect of antiplatelet therapies compared to standard techniques?
Does the Individual Platelet Adhesion Assay accurately measure platelet function and the effect of antiplatelet therapies compared to standard techniques?
A novel microarray-based assay accurately quantifies platelet adhesion and the effects of antiplatelet therapies, correlating well with standard techniques.
Answers are grounded in this paper and cite their sources.
The assay may advance preclinical platelet research; leaves open human validation before any clinical consideration.
Widespread monitoring of platelet function and the effect of antiplatelet drugs will improve outcomes in cardiovascular patients, but platelet function testing is not routine in clinical practice. We report a rapid, accurate methodology to quantify platelet-protein interactions: a microarray of contact-printed 6-μm fibrinogen dots on a transparent substrate binds platelets from whole blood, one platelet per dot. The fractional occupancy of an array of fibrinogen dots after a predefined incubation time quantitatively assays platelet adhesion to the protein matrix. We demonstrate this technique by measurement of platelet adhesion to fibrinogen as a means to quantify the effect of the P2Y12 and αIIbβ3 receptor inhibitors cangrelor and abciximab, respectively, both in vitro--by incubating the drug with a freshly drawn blood sample--and in blood from patients treated with antiplatelet agents. The effects of single- and dual-antiplatelet therapy are also assessed. Results from this platelet-binding assay are well correlated with standard techniques including flow cytometry and light transmission aggregometry. This assay technology, readily integrated with microfluidic platforms, is generally applicable to the assay of cell-protein interactions and promises more effective, rapid assay of drug effects in cardiovascular disease patients.
No takes yet. Share an insight, caveat, or question.
Lopez-Alonso et al. (2013) studied Cardiovascular disease. Individual Platelet Adhesion Assay vs. Standard techniques (flow cytometry and light transmission aggregometry) was evaluated on Correlation of platelet adhesion quantification with standard techniques. A novel microarray-based individual platelet adhesion assay successfully quantified the effects of antiplatelet therapies, correlating well with standard flow cytometry and aggregometry techniques.
Synapse has enriched 10 related papers. Consider them for comparative context: